Advertisement

Kidney and Adrenal Gland Cytology

  • Qing Kay Li
Chapter
Part of the Atlas of Anatomic Pathology book series (AAP)

Abstract

The critical role of fine needle aspiration (FNA) in the workup of the kidney and adrenal gland lesions continues to evolve and is also driven by current knowledge of the diseases as well as by clinical managements. Based on large-scale molecular studies and current knowledge, the WHO (World Health Organization) and ISUP (International Society of Urological Pathology) have updated the classification of urological lesions, particularly renal cell carcinoma (RCC); several newly recognized subtypes, including microphthalmia-associated transcription factor (MiT) family translocation (TFE3, TFEB, and MITF) RCC, are also documented as rare subtypes. Furthermore, the clinical detection rate of small renal masses (<4 cm in size) is on the rise, but the accurate diagnosis of these small masses still requires tumor tissue for morphological evaluation. Recently developed targeted therapies also demand that tumor tissue be obtained for molecular characterization. Therefore, an accurate diagnosis of a lesion and procurement of tumor tissue are critical steps in appropriate clinical management and the improvement of patients’ prognosis. Most FNAs are performed percutaneously through the abdominal wall anteriorly or by a flank approach posteriorly, under the guidance of CT, MRI, or ultrasound. In addition, endoscopic techniques, such as endoscopic ultrasound-guided FNA (EUS-FNA), are increasingly used in the biopsy of kidney and adrenal lesions in a subset of selected patients. As cytopathologists, we should understand the circumstances under which FNA is most often performed. This chapter summarizes the key FNA findings for cytomorphologic diagnosis of benign, malignant, and metastatic lesions of the kidney and adrenal gland.

Keywords

Kidney cytology Adrenal gland cytology Benign lesions Malignant tumors Metastatic tumors to the adrenal gland Ultrasound-guided fine needle aspiration CT-guided fine needle aspiration 

Notes

Acknowledgment

The author sincerely thanks Dr. David Borzik from the Department of Pathology at the Johns Hopkins Hospitals for his help with the chapter.

References

  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.CrossRefGoogle Scholar
  2. 2.
    Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, et al.; ISUP Renal Tumor Panel. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37:1469–89.Google Scholar
  3. 3.
    Delahunt B, Srigley JR. Renal neoplasia: from morphologic to molecular diagnosis. Semin Diagn Pathol. 2015;32:87–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Delahunt B, Srigley JR. The evolving classification of renal cell neoplasia. Semin Diagn Pathol. 2015;32:90–102.CrossRefPubMedGoogle Scholar
  5. 5.
    Huimiao J, Chepovetsky J, Zhou M, Sun W, Simsir A, Cohen D, Leung A. Mucinous tubular and spindle cell carcinoma of the kidney: diagnosis by fine needle aspiration and review of the literature. Cytojournal. 2015;12:28.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750–61.CrossRefPubMedGoogle Scholar
  7. 7.
    Argani P. MiT family translocation renal cell carcinoma. Semin Diagn Pathol. 2015;32:103–13.CrossRefPubMedGoogle Scholar
  8. 8.
    Smith NE, Illei PB, Allaf M, Gonzalez N, Morris K, Hicks J, et al. t(6;11) Renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases. Am J Surg Pathol. 2014;38:604–14.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Linehan WM. Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics. Genome Res. 2012;22:2089–100.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Riazalhosseini Y, Lathrop M. Precision medicine from the renal cancer genome. Nat Rev Nephrol. 2016;12:655–66.CrossRefPubMedGoogle Scholar
  11. 11.
    Li S, Shuch BM, Gerstein MB. Whole-genome analysis of papillary kidney cancer finds significant noncoding alterations. PLoS Genet. 2017;13:e1006685.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Srinivasan R, Ricketts CJ, Linehan WM. New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease. Clin Cancer Res. 2015;21:10–7.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499:43–9.CrossRefGoogle Scholar
  14. 14.
    Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, et al.; The Cancer Genome Atlas Research Network. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26:319–30.Google Scholar
  15. 15.
    Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374:135–45.CrossRefGoogle Scholar
  16. 16.
    Lam AK. Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol. 2017;28:213–27.  https://doi.org/10.1007/s12022-017-9484-5.CrossRefPubMedGoogle Scholar
  17. 17.
    Melo-Leite AF, Elias PC, Teixeira SR, Tucci S, Barros GE, Antonini SR, et al. Adrenocortical neoplasms in adulthood and childhood: distinct presentation. Review of the clinical, pathological and imaging characteristics. J Pediatr Endocrinol Metab. 2017;30:253–76.CrossRefPubMedGoogle Scholar
  18. 18.
    Faillot S, Assie G. Endocrine tumors: the genomics of adrenocortical tumors. Eur J Endocrinol. 2016;174:R249–65.CrossRefPubMedGoogle Scholar
  19. 19.
    Dusenbery D, Dekker A. Needle biopsy of the adrenal gland: retrospective review of 54 cases. Diagn Cytopathol. 1996;14:126–34.CrossRefPubMedGoogle Scholar
  20. 20.
    Lam KY, Lo CY. Metastatic tumors of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol. 2002;56:95–101.CrossRefGoogle Scholar
  21. 21.
    Bancos I, Tamhane S, Shah M, Delivanis DA, Alahdab F, Arlt W, et al. Diagnosis of endocrine disease: the diagnostic performance of adrenal biopsy: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175:R65–80.CrossRefPubMedGoogle Scholar
  22. 22.
    Duregon E, Volante M, Bollito E, Goia M, Buttigliero C, Zaggia B, et al. Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases. Hum Pathol. 2015;46:1799–807.CrossRefPubMedGoogle Scholar
  23. 23.
    Diaz de Leon A, Pedrosa I. Imaging and screening of kidney cancer. Radiol Clin North Am. 2017;55:1235–50.CrossRefPubMedGoogle Scholar
  24. 24.
    Patel BN, Bibbey A, Choudhury KR, Leder RA, Nelson RC, Marin D. Characterization of small (<4 cm) focal renal lesions: diagnostic accuracy of spectral analysis using single-phase contrast-enhanced dual-energy CT. AJR Am J Roentgenol. 2017;209:815–25.CrossRefPubMedGoogle Scholar
  25. 25.
    Marcelin C, Ambrosetti D, Bernhard JC, Roy C, Grenier N, Cornelis FH. Percutaneous image-guided biopsies of small renal tumors: current practice and perspectives. Diagn Interv Imaging. 2017;98:589–99.CrossRefPubMedGoogle Scholar
  26. 26.
    Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol. 2016;69:660–73.CrossRefPubMedGoogle Scholar
  27. 27.
    Yang CS, Choi E, Idrees MT, Chen S, Wu HH. Percutaneous biopsy of the renal mass: FNA or core needle biopsy? Cancer Cythopathol. 2017;125:407–15.CrossRefGoogle Scholar
  28. 28.
    Lopes RI, Moura RN, Artifon E. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of kidney lesions: a review. World J Gastrointest Endosc. 2015;7:253–7.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Jhala NC, Jhala D, Eloubeidi MA, Chhieng DC, Crowe DR, Roberson J, Eltoum I. Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: analysis of 24 patients. Cancer. 2004;102:308–14.CrossRefPubMedGoogle Scholar
  30. 30.
    Jiménez-Heffernan JA, Vicandi B, López-Ferrer P, González-Peramato P, Pérez-Campos A, Viguer JM. Cytologic features of pheochromocytoma and retroperitoneal paraganglioma: a morphologic and immunohistochemical study of 13 cases. Acta Cytol. 2006;50:372–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Guo Z, Lloyd RV. Pheochromocytomas and paragangliomas: an update on recent molecular genetic advances and criteria for malignancy. Adv Anat Pathol. 2015;22:283–93.CrossRefPubMedGoogle Scholar
  32. 32.
    Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287:1427–34.CrossRefPubMedGoogle Scholar
  33. 33.
    DeMay RM. The art and science of cytopathology, exfoliative cytology, vol. 1. 2nd ed. Chicago: ASCP Press; 2012.Google Scholar
  34. 34.
    Cibas ES. Peritoneal washings. In: Cibas ES, Ducatman BS, editors. Cytology: diagnostic principles and clinical correlates. Philadelphia: Saunders/Elsevier; 2014. p. 155–70.Google Scholar
  35. 35.
    Barkan GA, Wojcik EM. Genitourinary cytopathology (kidney and urinary tract). Cancer Treat Res. 2014;160:149–83.CrossRefPubMedGoogle Scholar
  36. 36.
    Chandrasekar T, Ahmad AE, Fadaak K, Jhaveri K, Bhatt JR, Jewett MAS, Finelli A. Natural history of complex renal cysts: clinical evidence supporting active surveillance. J Urol. 2017;199:633–40.  https://doi.org/10.1016/j.juro.2017.09.078.CrossRefGoogle Scholar
  37. 37.
    Weibl P, Hora M, Kollarik B, Kalusova K, Pitra T, Remzi M, et al. A practical guide and decision-making protocol for the management of complex renal cystic masses. Arab J Urol. 2017;15:115–22.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Schoots IG, Zaccai K, Hunink MG, Verhagen PCMS. Bosniak classification for complex renal cysts reevaluated: a systematic review. J Urol. 2017;198:12–21.CrossRefPubMedGoogle Scholar
  39. 39.
    Sevcenco S, Spick C, Helbich TH, Heinz G, Shariat SF, Klingler HC, et al. Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography—a systematic review and meta-analysis. Eur Radiol. 2017;27:2239–47.CrossRefPubMedGoogle Scholar
  40. 40.
    Raso DS, Greene WB, Finley JL, Silverman JF. Morphology and pathogenesis of Liesegang rings in cyst aspirates: report of two cases with ancillary studies. Diagn Cytopathol. 1998;19:116–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Stevens S, McClure J. The histochemical features of the Michaelis-Gutmann body and a consideration of the pathophysiological mechanisms of its formation. J Pathol. 1982;137:119–27.CrossRefPubMedGoogle Scholar
  42. 42.
    Leone AR, Kidd LC, Diorio GJ, Zargar-Shoshtari K, Sharma P, Sexton WJ, Spiess PE. Bilateral benign renal oncocytomas and the role of renal biopsy: single institution review. BMC Urol. 2017;17:6.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Liu J, Fanning CV. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies. Cancer. 2001;93:390–7.CrossRefPubMedGoogle Scholar
  44. 44.
    Zhou H, Guo M, Gong Y. Challenge of FNA diagnosis of angiomyolipoma: a study of 33 cases. Cancer. 2017;125:257–66.Google Scholar
  45. 45.
    Reuter VE, Argani P, Zhou M, Delahunt B, Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38:e35–49.CrossRefPubMedGoogle Scholar
  46. 46.
    Salamanca J, Alberti N, López-Ríos F, Perez-Barrios A, Martínez-González MA, de Agustín P. Fine needle aspiration of chromophobe renal cell carcinoma. Acta Cytol. 2007;51:9–15.CrossRefPubMedGoogle Scholar
  47. 47.
    Ng KL, Morais C, Bernard A, Saunders N, Samaratunga H, Gobe G, et al. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma. J Clin Pathol. 2016;69:661–71.CrossRefPubMedGoogle Scholar
  48. 48.
    Powers CN, Elbadawi A. “Cercariform” cells: a clue to the cytodiagnosis of transitional cell origin of metastatic neoplasms? Diagn Cytopathol. 1995;13:15–21.CrossRefPubMedGoogle Scholar
  49. 49.
    Subhawong AP, Subhawong TK, Li QK. Fine needle aspiration of a metastatic prostate carcinoma simulating a primary adrenal cortical neoplasm: a case report and review of literature. Diagn Cytopathol. 2010;38:147–53.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pathology and OncologyThe Johns Hopkins Medical InstitutionsBaltimoreUSA

Personalised recommendations